Janus Henderson Group
ADMS

Janus Henderson Group’s Adamas Pharmaceuticals ADMS Stock Holding History

Janus Henderson Group’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-907,415
Closed -$18.2M – 1449
2018
Q3 		$18.2M Sell
907,415
-9,571
-1% -$225K 0.01% 837
2018
Q2 		$23.7M Sell
916,986
-3,673
-0.4% -$102K 0.01% 760
2018
Q1 		$22M Buy
+920,659
New +$29M 0.01% 775

Other funds holding ADMS

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Janus Henderson Group's ADMS Position: Q4 2018 in Review

Janus Henderson Group sold out of Adamas Pharmaceuticals (ADMS) in Q4 2018, closing a stake of 907,415 shares — an estimated $18.2M sold.

Janus Henderson Group first reported a position in ADMS in Q1 2018 and held it in 3 quarters. The position peaked at $23.7M in Q2 2018. 98 funds tracked by Wall St. Rank hold ADMS as of Q4 2018.

  • Janus Henderson Group reported no remaining Adamas Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Janus Henderson Group sold 907,415 Adamas Pharmaceuticals shares in Q4 2018, an estimated $18.2M.
  • Janus Henderson Group first reported a position in Adamas Pharmaceuticals in Q1 2018 and held it in 3 quarters.
  • Janus Henderson Group's Adamas Pharmaceuticals position peaked at $23.7M in Q2 2018.
  • 98 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2018.

Based on Janus Henderson Group's 13F filing for Q4 2018, filed 6 Feb 2019.